Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model

Journal:

The New England Journal of Medicine

Published:

2025-11-27

DOI:

10.1056/nejmoa2500179

Affiliations:

7

Authors:

27

Go to article

Institutions	Authors	Share
Johnson & Johnson, Belgium, Belgium	10.000000 10.000000	0.37
Johns Hopkins University (JHU), United States of America (USA)	6.000000	0.22
Johnson & Johnson, United States of America (USA)	5.000000	0.19
University of Vermont (UVM), United States of America (USA)	4.000000	0.15
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	2.000000	0.07

Interested in Clinical Sciences?